Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANDREY ESPINOZA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1255384897
CMS profile
56892
Location
FLEMINGTON, NJ

General Payments · PY2018–2024

$64,381.53

  • Reported across 312 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,083.72

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $586.78 3
Food and Beverage $496.94 13

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $5,244.09 112
PY2019 $3,892.34 67
PY2020 $695.23 24
PY2021 $16,778.93 29
PY2022 $16,064.35 30
PY2023 $20,622.87 34
PY2024 $1,083.72 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.66 12/30/2024 Food and Beverage Undisputed 01/23/2026 1124924904 CMS
Amgen Inc. $16.34 05/23/2024 Food and Beverage Undisputed 01/23/2026 1111571157 CMS
Endologix LLC $243.07 06/10/2024 Food and Beverage Undisputed 01/23/2026 1116757621 CMS
Esperion Therapeutics, Inc. $14.84 05/30/2024 Food and Beverage Undisputed 01/23/2026 1129434368 CMS
iRhythm Technologies, Inc. $43.94 10/23/2024 Food and Beverage Undisputed 01/23/2026 1154055562 CMS
Kiniksa Pharmaceuticals International, plc $15.92 05/30/2024 Food and Beverage Undisputed 01/23/2026 1154854074 CMS
Lilly USA, LLC $22.95 05/15/2024 Food and Beverage Undisputed 01/23/2026 1136040350 CMS
Medtronic, Inc. $23.12 04/10/2024 Food and Beverage Undisputed 01/23/2026 1117130397 CMS
Medtronic, Inc. $24.12 09/19/2024 Food and Beverage Undisputed 01/23/2026 1117130399 CMS
Novartis Pharmaceuticals Corporation $17.37 05/02/2024 Food and Beverage Undisputed 01/23/2026 1086944787 CMS
Novartis Pharmaceuticals Corporation $17.85 05/16/2024 Food and Beverage Undisputed 01/23/2026 1086944791 CMS
Novartis Pharmaceuticals Corporation $16.12 06/04/2024 Food and Beverage Undisputed 01/23/2026 1086944793 CMS
Philips North America LLC $41.00 04/01/2024 Travel and Lodging Undisputed 01/23/2026 1146887254 CMS
Philips North America LLC $238.78 04/01/2024 Travel and Lodging Undisputed 01/23/2026 1146887256 CMS
Philips North America LLC $307.00 04/01/2024 Travel and Lodging Undisputed 01/23/2026 1146887258 CMS
SCPHARMACEUTICALS INC. $19.64 05/15/2024 Food and Beverage Undisputed 01/23/2026 1132275610 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.